Georgetn Univ Lombardi Can Ctr — Washington D.C., District of Columbia

Georgetn Univ Lombardi Can Ctr is a clinical research site located in Washington D.C., District of Columbia, United States 20007.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Georgetn Univ Lombardi Can Ctr has participated in 2 clinical trials.

Therapeutic areas: Colorectal Cancer, Metastatic Pancreatic Cancer.

Sponsors: Bristol-Myers Squibb, R-Pharm.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Georgetn Univ Lombardi Can Ctr?

Georgetn Univ Lombardi Can Ctr has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Georgetn Univ Lombardi Can Ctr conducted?

Georgetn Univ Lombardi Can Ctr has 2 clinical trials on record. Their work covers Colorectal Cancer, Metastatic Pancreatic Cancer.

Is Georgetn Univ Lombardi Can Ctr accredited by Crixeo Health?

Georgetn Univ Lombardi Can Ctr has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Georgetn Univ Lombardi Can Ctr?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.